“By integrating into the Glooko diabetes management platform, we now provide safe and secure access to meaningful diabetes information, beyond just device data, and new disease management solutions. Our partnership with Glooko reflects our overall strategy to become a holistic diabetes management company and provide new solutions for people with diabetes, for greater freedom and better health,” Medtronic diabetes division president Annette Brüls said in prepared remarks.
Fridley, Minn.-based Medtronic took part in a $17 million Series B round for Glooko last year.
“Providing users of Medtronic insulin pumps and sensors with retrospective insights about their insulin dosing and its impact on their glucose levels on their phone can make a real difference in their overall health and outcomes,” added Glooko CEO Rick Altinger. “Being the first to deliver a remote patient monitoring and mobile health solution that includes Medtronic data provides the patient population with a capability that can really have an impact.”